# Teriparatide as a Chondroregenerative Therapy in OA

> **NCT03072147** · PHASE2 · COMPLETED · sponsor: **Christopher Ritchlin** · enrollment: 76 (actual)

## Conditions studied

- Knee Osteoarthritis
- Cartilage Degeneration

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03072147
- **Lead sponsor:** Christopher Ritchlin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2023-05-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03072147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03072147, "Teriparatide as a Chondroregenerative Therapy in OA". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03072147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*